Starling Oncology, Inc.: common_shares_issued
| Value | {"unit": "shares", "value": 101707558, "concept": "us-gaap:CommonStockSharesIssued"} |
|---|---|
| Period | (as of 2026-03-31) |
| Status | current |
| Entity | Starling Oncology, Inc. |
Provenance
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
Retrieved: 2026-08-19T18:08:38.724184+02:00
Raw response sha256:
Also addressable by official identifiers:
Cite as: FACTANKER, https://factanker.com/fact/c99d3acb-6fd8-49b4-ab76-9691f5cbf222
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
0001799191-26-000010Retrieved: 2026-08-19T18:08:38.724184+02:00
Raw response sha256:
f7bde1a401b286c74a2fd824ee1df541…Also addressable by official identifiers:
https://factanker.com/fact/sec/cik-0001799191/common-shares-issued/2026-03-31 (CIK, metric, reporting date)Cite as: FACTANKER, https://factanker.com/fact/c99d3acb-6fd8-49b4-ab76-9691f5cbf222
History
- no predecessors — first report